66 related articles for article (PubMed ID: 38653507)
1. The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023.
Foley DA; Minney-Smith CA; Tjea A; Nicol MP; Levy A; Moore HC; Blyth CC
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793538
[TBL] [Abstract][Full Text] [Related]
2. Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
Surie D; Yuengling KA; DeCuir J; Zhu Y; Lauring AS; Gaglani M; Ghamande S; Peltan ID; Brown SM; Ginde AA; Martinez A; Mohr NM; Gibbs KW; Hager DN; Ali H; Prekker ME; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Leis AM; Khan A; Hough CL; Bender WS; Duggal A; Bendall EE; Wilson JG; Qadir N; Chang SY; Mallow C; Kwon JH; Exline MC; Shapiro NI; Columbus C; Vaughn IA; Ramesh M; Mosier JM; Safdar B; Casey JD; Talbot HK; Rice TW; Halasa N; Chappell JD; Grijalva CG; Baughman A; Womack KN; Swan SA; Johnson CA; Lwin CT; Lewis NM; Ellington S; McMorrow ML; Martin ET; Self WH;
JAMA Netw Open; 2024 Apr; 7(4):e244954. PubMed ID: 38573635
[TBL] [Abstract][Full Text] [Related]
3. Surveillance outcomes of respiratory pathogen infections during the 2021-2022 season among U.S. Military Health System beneficiaries, October 3, 2021-October 1, 2022.
Kwaah B; Gruner WE; DeMarcus LS; Thervil JW; Jenkins WN; Castillo FM; Hartless TR; Heh VK; Muehleman D; Fries AC; Sjoberg PA; Evengue FE; Robbins AS
MSMR; 2024 May; 31(5):16-23. PubMed ID: 38857490
[TBL] [Abstract][Full Text] [Related]
4. Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS).
Del Riccio M; Caini S; Bonaccorsi G; Lorini C; Paget J; van der Velden K; Meijer A; Haag M; McGovern I; Zanobini P
Int J Infect Dis; 2024 Jul; 144():107052. PubMed ID: 38636684
[TBL] [Abstract][Full Text] [Related]
5. Pre-admission virus detection during the COVID-19 pandemic in children with and without symptoms of infection.
Bennet R; Rinder MR; George E; Hertting O; Luthander J; Åkefeldt SO; Hammas B; Allander T; Eriksson M
Acta Paediatr; 2024 Jul; 113(7):1679-1684. PubMed ID: 38445712
[TBL] [Abstract][Full Text] [Related]
6. Electronic Health Record-Based Algorithm for Monitoring Respiratory Virus-Like Illness.
Cocoros NM; Eberhardt K; Nguyen VT; Brown CM; DeMaria A; Madoff LC; Randall LM; Klompas M
Emerg Infect Dis; 2024 Jun; 30(6):1096-1103. PubMed ID: 38781684
[TBL] [Abstract][Full Text] [Related]
7. Implementation and evaluation of a SARI surveillance system in a tertiary hospital in Scotland in 2021/2022.
Evans JMM; Young JJ; Mutch H; Blunsum A; Quinn J; Lowe DJ; Ho A; Marsh K; Mokogwu D
Public Health; 2024 Jul; 232():114-120. PubMed ID: 38772199
[TBL] [Abstract][Full Text] [Related]
8. Nowcasting methods to improve the performance of respiratory sentinel surveillance: lessons from the COVID-19 pandemic.
Flores-Alvarado S; Olivares MF; Vergara N; García C; Canals M; Cuadrado C
Sci Rep; 2024 May; 14(1):12582. PubMed ID: 38822070
[TBL] [Abstract][Full Text] [Related]
9. Modeling the transmission mitigation impact of testing for infectious diseases.
Middleton C; Larremore DB
Sci Adv; 2024 Jun; 10(24):eadk5108. PubMed ID: 38875334
[TBL] [Abstract][Full Text] [Related]
10. Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing.
Petros BA; Milliren CE; Sabeti PC; Ozonoff A
medRxiv; 2024 Feb; ():. PubMed ID: 38405774
[TBL] [Abstract][Full Text] [Related]
11. The COVID-19 Community Research Partnership: a multistate surveillance platform for characterizing the epidemiology of the SARS-CoV-2 pandemic.
COVID-19 Community Research Partnership
Biol Methods Protoc; 2022; 7(1):bpac033. PubMed ID: 36589317
[TBL] [Abstract][Full Text] [Related]
12. Adjusting Incidence Estimates with Laboratory Test Performances: A Pragmatic Maximum Likelihood Estimation-Based Approach.
Weng Y; Tian L; Boothroyd D; Lee J; Zhang K; Lu D; Lindan CP; Bollyky J; Huang B; Rutherford GW; Maldonado Y; Desai M;
Epidemiology; 2024 May; 35(3):295-307. PubMed ID: 38465940
[TBL] [Abstract][Full Text] [Related]
13. Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024.
Tuttle A; Hughes CM; Dvorak M; Aeschleman L; Davidson W; Wilkins K; Gigante C; Satheshkumar PS; Rao AK; Minhaj FS; Christensen BE; McQuiston JH; Hutson CL; McCollum AM
MMWR Morb Mortal Wkly Rep; 2024 May; 73(20):474-476. PubMed ID: 38781102
[No Abstract] [Full Text] [Related]
14. Estimating the incidence of COVID-19, influenza and respiratory syncytial virus infection in three regions of Queensland, Australia, winter 2022: findings from a novel longitudinal testing-based sentinel surveillance programme.
May F; Ginige S; Firman E; Li YS; Soonarane YK; Smoll N; Hunter I; Pery B; Macfarlane B; Bladen T; Allen T; Green T; Walker J; Slinko V; Stickley M; Khandaker G; Anuradha S; Wattiaux A
BMJ Open; 2024 Apr; 14(4):e081793. PubMed ID: 38653507
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a winter sentinel surveillance program of notifiable respiratory viruses in Queensland.
Ginige S; Firman E; Li YS; Soonarane Y; Smoll N; May F; Hunter I; Pery B; Macfarlane B; Bladen T; Allen T; Lennon M; Walker J; Slinko V; Stickley M; Khandaker G; Anuradha S; Wattiaux A
PLoS One; 2022; 17(11):e0277895. PubMed ID: 36441699
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort.
Dietz E; Pritchard E; Pouwels K; Ehsaan M; Blake J; Gaughan C; Haduli E; Boothe H; Vihta KD; Peto T; Stoesser N; Matthews P; Taylor N; Diamond I; Studley R; Rourke E; Birrell P; De Angelis D; Fowler T; Watson C; Eyre D; House T; Walker AS
BMC Med; 2024 Mar; 22(1):143. PubMed ID: 38532381
[TBL] [Abstract][Full Text] [Related]
17. Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era.
Luštrek M; Cesar Z; Suljič A; Kogoj R; Knap N; Virant MJ; Uršič T; Petrovec M; Avšič-Županc T; Korva M
Respir Res; 2024 Jun; 25(1):234. PubMed ID: 38840154
[TBL] [Abstract][Full Text] [Related]
18. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.
Weidmann MD; Green DA; Berry GJ; Wu F
Front Cell Infect Microbiol; 2023; 13():1208235. PubMed ID: 37389220
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
